首页> 外文会议>World biomaterials congress >Influence of molecular architecture in the design and development of a pH-responsive nanoscale hydrogel platform for tumor-targeted drug delivery
【24h】

Influence of molecular architecture in the design and development of a pH-responsive nanoscale hydrogel platform for tumor-targeted drug delivery

机译:分子结构在设计和开发用于肿瘤靶向药物递送的pH响应纳米级水凝胶平台的设计和开发中的影响

获取原文

摘要

The lack of specificity in traditional chemotherapeutic administration typically leads to significant dose-limiting toxicities and requires patients to wait for long periods between treatments. During this time, cancer cells have an opportunity to recover from the treatment and develop multi-drug resistance. Our work holds promise to improve treatment specificity through the use of intelligent nanoscale hydrogels (nanogels) to localize the chemotherapeutic agents (CA) at targeted disease sites via the enhanced permeation and retention effect, ultimately limiting the toxicity to healthy tissues. Further, the nanogel molecular architecture can be tailored to carry a variety of cargos with widely varying physicochemical properties, promote cellular uptake, and release the cargo only in response to the intracellular environment. Nanoparticle-mediated combination therapy offers many advantages including the ability to signal different pathways in the cancer cells, maximize the therapeutic efficacy against specific targets, target different phases of the cell cycle, and overcome efflux-driven mechanisms of resistance. Further, it allows PK/PD to be dictated by the in vivo distribution and cellular uptake of the nanogels rather than the physicochemical properties of the free CAs, ensuring optimal synergistic ratios are delivered to the cytosol. As shown in Fig. 1 A, the nanogels are comprised of: 1) a cationic monomer 2-(diethylamino)ethyl methacrylate that imparts the pH-response by ionization of amine pendant groups, 2) a tetraethylene glycol dimethacrylate crosslinker to improve CA retention, 3) an alkyl methacrylate monomer to improve CA-polymer interactions, 4) surface-grafted poly(ethylene glycol) methacrylate to impart serum stability. Nanogels were synthesized using a UV-initiated oil-in-water emulsion polymerization with a 2.5 mol% crosslinking density. The impact of alkyl methacrylate monomer inclusion was investigated through systematic variation of monomer functionality and chain length (methyl methacrylate, ethyl methacrylate, isopropyl methacrylate, tert-butyl methacrylate, cyclohexyl methacrylate, butyl methacrylate, and hexyl methacrylate as shown in Fig. 1B). The physical properties of the resulting nanogels were compared using dynamic light scattering, zeta potential, titration, pyrene fluorescence, and red blood cell hemolysis as a function of pH to elicit the influence of polymer composition on swelling ratio, surface charge, pKa, relative hydrophobicity and hydrophile-hydrophobe phase transition, and erythrocyte membrane disruption capability. The therapeutic delivery potential was analyzed using hydrophobic (paclitaxel) and hydrophilic (carboplatin) chemotherapeutic agents. Nanogels were loaded by imbibition at pH 4.0, and the release kinetics were studied by incubating loaded nanogels at pH 7.4 for 2 hr followed by pH 5.5 for 24 hr. The nanogels resulted in well-defined and controllable particle size, morphology, and composition. We demonstrated the tunability of our multicomponent nanogel systems to entrap varied molecular cargos, and showed that the molecular architecture can be rationally designed to respond intelligently to different environments. As shown in Fig. 2a and 2b, inclusion of a hydrophobic monomer significantly altered the resulting nanogel physical properties. Varying both the chain length and steric bulk allowed for precise control over the thermodynamic response (relative swelling ratio), dynamic behavior (nanogel pKa and membrane disruption potential), and CA-polymer interaction (therapeutic delivery potential). Nanogels synthesized with hexyl methacrylate exhibited favorable behavior for intracellular delivery and demonstrated an increase in the therapeutic delivery potential of both hydrophobic and hydrophilic CAs. The 90-nm nanogels (hydrodynamic diameter) exhibited a neutral surface charge and no hemolytic activity in pH 7.4 PBS, indicating stability in a simulated physiological environment and ability to retain the CAs during circulation in the bloodstream. The nanogels swelled to 120-nm in response to acidic pH and demonstrated significant membrane disruption in PBS with pH < 6.8, demonstrating the ability to rapidly release the encapsulated CAs and mediate endosomal rupture in a pH-dependent manner.
机译:传统化学疗法给药中缺乏特异性通常导致明显的剂量限制性毒性,并要求患者在两次治疗之间等待较长时间。在这段时间内,癌细胞有机会从治疗中恢复并发展多药耐药性。我们的工作有望通过使用智能纳米级水凝胶(nanogels)通过增强的渗透和保留作用,将化学治疗剂(CA)定位在目标疾病部位来改善治疗特异性,最终限制对健康组织的毒性。此外,可以定制纳米凝胶分子结构以携带具有广泛变化的理化性质的各种货物,促进细胞摄取并仅响应于细胞内环境而释放货物。纳米粒子介导的联合疗法具有许多优势,包括能够在癌细胞中发出不同信号的信号,使针对特定靶标的治疗功效最大化,靶向细胞周期的不同阶段以及克服外排驱动的耐药机制。此外,它允许PK / PD由纳米凝胶的体内分布和细胞摄取决定,而不是由游离CA的物理化学性质决定,从而确保将最佳的协同作用比例传递至细胞质。如图1 A所示,纳米凝胶包括:1)阳离子单体2-(二乙基氨基)乙基甲基丙烯酸酯,可通过胺侧基的电离作用赋予pH响应; 2)四乙二醇二甲基丙烯酸酯交联剂,可改善CA保留; 3)甲基丙烯酸烷基酯单体,以改善CA-聚合物之间的相互作用; 4)表面接枝的聚(甲基乙二醇)甲基丙烯酸酯,以赋予血清稳定性。使用具有2.5 mol%交联密度的UV引发的水包油乳液聚合法合成了纳米凝胶。通过系统地改变单体官能度和链长(甲基丙烯酸甲酯,甲基丙烯酸乙酯,甲基丙烯酸异丙酯,甲基丙烯酸叔丁酯,甲基丙烯酸环己酯,甲基丙烯酸丁酯和甲基丙烯酸己酯),研究了甲基丙烯酸烷基酯单体夹杂物的影响。使用动态光散射,ζ电位,滴定,pyr荧光和红细胞溶血随pH的变化来比较所得纳米凝胶的物理性质,以引起聚合物组成对溶胀率,表面电荷,pKa,相对疏水性的影响和亲水-疏水相变和红细胞膜破坏能力。使用疏水性(紫杉醇)和亲水性(卡铂)化学治疗剂分析了治疗的交付潜力。通过在pH 4.0的吸收作用负载纳米凝胶,并通过在pH 7.4的负载纳米凝胶中孵育2小时,然后在pH 5.5的条件下孵育24小时来研究释放动力学。纳米凝胶产生了明确定义且可控制的粒径,形态和组成。我们证明了我们的多组分纳米凝胶系统可捕获各种分子货物的可调性,并表明可以合理设计分子结构以对不同环境进行智能响应。如图2a和2b所示,包含疏水性单体显着改变了所得纳米凝胶的物理性质。改变链长和空间体积都可以精确控制热力学响应(相对溶胀率),动力学行为(纳米凝胶pKa和膜破坏电位)和CA-聚合物相互作用(治疗传递电位)。用甲基丙烯酸己酯合成的纳米凝胶对细胞内递送表现出良好的行为,并证明疏水性和亲水性CA的治疗性递送潜力均增加。 90 nm纳米凝胶(流体动力学直径)在pH 7.4 PBS中显示中性表面电荷,无溶血活性,表明在模拟生理环境中具有稳定性,并在血液循环过程中保留CAs。纳米凝胶响应酸性pH溶胀至120 nm,并在pH <6.8的PBS中显示出明显的膜破裂,证明了能够以pH依赖的方式快速释放包封的CAs和介导内体破裂的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号